We are looking for children to join a Crohn’s disease medical research study to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or Crohn’s and ulcerative colitis (including associated symptoms such as swollen joints, failure to thrive, rectal pain, malnutrition and/or joint pain), consider one of our Crohn’s disease (CD) research. All eligible participants will receive no-cost study-related care and study medication. Your children may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

We are looking for 2–17 year olds to join a Crohn’s disease clinical research study to help us discover more about treating inflammatory bowel disease. If you are looking for a potential new treatment option for inflammatory bowel disease or moderate to severe UC (including associated symptoms such as abdominal pain or cramping, growth failure, cramps, chronic fatigue and/or eye pain), consider one of our Crohn’s disease (CD) clinical research. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

We are looking for children 2 to 17 years old to join a research study to help us discover more about treating Crohn’s and ulcerative colitis. If you are looking for a potential new treatment option for Crohn’s and ulcerative colitis or moderate to severe CD (including associated symptoms such as diarrhea with blood and pus, reduced appetite, diarrhea, weight loss and/or anemia), consider one of our CD and UC studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the CD and UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

Is your child currently experiencing inflammatory bowel disease flare-ups? Local trial is testing a potential new medication to see if it may reduce rectal pain, loss of appetite, cramps, frequent fevers, and/or eye pain associated with inflammatory bowel disease.
If you’re concerned about how inflammatory bowel disease affects your child’s life, find out more about the trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

We are looking for child to join a Crohn’s disease trial to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or Crohn’s disease (CD) (including associated symptoms such as stomach pain, unexplained weight loss, abdominal pain, frequent fevers and/or anemia), consider one of our Crohn’s disease studies. All eligible participants will receive no-cost study-related care and study medication. Your child may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

We are looking for young people at least 2 years of age but under 18 to join a research study to help us discover more about treating inflammatory bowel disease. If you are looking for a potential new treatment option for inflammatory bowel disease or moderately to severely active IBD (including associated symptoms such as recurrent diarrhea, loss of appetite, diarrhea, malnutrition and/or eye pain), consider one of our GI clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the GI clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing moderate to severe ulcerative colitis flare-ups? Local Crohn’s disease clinical research is testing a potential new medication to see if it may reduce fatigue, inflammation of the bowel or intestine, diarrhea, malnutrition, and/or canker sores associated with moderate to severe ulcerative colitis.
If you’re concerned about how moderate to severe ulcerative colitis affects your child’s life, find out more about the Crohn’s disease clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to take part.

Is your child currently experiencing moderately to severely active IBD flare-ups? Local clinical research study is testing a potential new medication to see if it may reduce abdominal pain and cramps, blood in the stool, bloody stool, weight loss, and/or eye pain associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

We are looking for young people 2–17 years old to join a Crohn’s disease (CD) medical research study to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or ulcerative colitis (UC) (including associated symptoms such as joint pain, kidney stones, cramps, weight loss and/or canker sores), consider one of our Crohn’s disease (CD) research. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

We are looking for children 2–17 years of age to join a CD study to help us discover more about treating CD. If you are looking for a potential new treatment option for CD or CD (including associated symptoms such as swollen joints, failure to thrive, constant need to poop, frequent fevers and/or eye pain), consider one of our Crohn’s disease studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?